Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

NCT06007937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering West Harrison (All Protocol Activities) Harrison, New York, United States
View Trial Details
Active, not recruiting

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

NCT02971501

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 18 locations
View Trial Details
Active, not recruiting

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • XCancer/Dothan Hematology & Oncology - 1114 Dothan, Alabama, United States
  • Genesis Cancer and Blood Institute - 1123 Russellville, Arkansas, United States
  • The Oncology Institute (TOI) Clinical Research - 1109 Cerritos, California, United States
  • Emad Ibrahim MD Inc. - 1147 Redlands, California, United States
View all 152 locations
View Trial Details
Active, not recruiting

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

NCT04603807

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Oncocentro Serviços Médicos e Hospitalares Ltda Fortaleza, Ceará, Brazil
  • Hospital Sao Rafael - HSR Salvador, Estado de Bahia, Brazil
  • Hospitais Integrados da Gavea S/A Brasília, Federal District, Brazil
  • Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN Florianópolis, Santa Catarina, Brazil
View all 61 locations
View Trial Details
Active, not recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, not recruiting

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

NCT04685135

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Local Institution - 012-898 Cerritos, California, United States
  • Local Institution - 012-898 D Glendale, California, United States
  • Local Institution - 012-910-A Huntington Beach, California, United States
  • Local Institution - 012-910-C Irvine, California, United States
View all 380 locations
View Trial Details
Active, not recruiting

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

NCT03600701

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 18 locations
View Trial Details

Related conditions